The market for pharmaceutical filtration is expected to exhibit significant growth in the upcoming decade, from 2023 to 2033, with a CAGR of 8.9%. The global pharmaceutical filtration market is anticipated to reach US$ 45.08 billion by 2033. As of 2023, the current market valuation is US$ 19.19 billion.
Key Market Highlights
Pharmaceutical Filtration Becomes a Crucial Factor in the Growth of Biopharmaceutical Industry
The significance of biopharmaceutical drugs and vaccines came to light in the recent pandemic that hit the world. Biopharmaceuticals-drugs, vaccines, and gene therapies-are specialized medicines derived from living organisms. As these drugs are highly complex to manufacture, there is little to no chance of impurities, contaminants, or changes in their environment. The manufacturing process involves precise filtration of these unwanted particles, which is done through pharmaceutical filtration.
Pharmaceutical filtration also removes cellular debris, extra proteins, and harmful contaminants from the product, keeping the active pharmaceutical ingredient (API) pure and safe. The filtration process, in the end, is also important because any impurities in the final product can be fatal for patients consuming it. With the rise in chronic diseases such as heart disease, cancer, and diabetes, pharmaceutical filtration can be in great demand in the upcoming years.
Emerging Gene Therapy Market to Fetch Huge Demand for Pharmaceutical Filtration
According to the study conducted by Future Market Insights, there are currently 2,000 gene therapy products in the development process. Like biopharmaceuticals, the production of gene therapy products also involves an intense filtration process to remove all the foreign elements in the final drug. This rise in demand for gene therapy products is set to increase the global pharmaceutical filtration market in the years to come.
Pharmaceutical companies have invested billions of dollars in the research and development of gene therapy products. They are relatively more effective in the treatment of cancer, cardiovascular disease, and neurodegenerative diseases. As gene therapy continues to offer new hope to patients suffering from such diseases, it is also noteworthy that there is a promising rise in the demand for pharmaceutical filtration products.
| Attributes | Key Statistics |
|---|---|
| Expected Base Year Value (2023) | US$ 19.19 billion |
| Anticipated Forecast Value (2033) | US$ 45.08 billion |
| Estimated Growth (2023 to 2033) | 8.9% CAGR |
The market is still growing, and there is room for research and development in the industry. The pharmaceutical filtration market may foresee a significant surge as the industry progresses.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global pharmaceutical filtration market size was valued at US$ 17.84 billion in 2022. In 2018, the net revenue from total sales of pharmaceutical filtration was around US$ 12.59 billion. Over the historical period, the overall market value was expanded at a compound annual growth rate (CAGR) of 7.2%. By the end of the forecast period in 2033, this value is projected to reach an estimated US$ 45.08 billion.
| Attributes | Key Statistics |
|---|---|
| Expected Base Year Value (2017) | US$ 12.59 billion |
| Anticipated Forecast Value (2022) | US$ 17.84 billion |
| Estimated Growth (2017 to 2022) | 7.2% CAGR |
The recent pandemic saw a tremendous expansion in the production of vaccines and medications worldwide. These new market opportunities proved to be very beneficial for the growth of the pharmaceutical filtration market in recent years.
Principal Consultant
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Countries | Value Share in 2023 |
|---|---|
| The United States | 27.6% |
| India | 12.5% |
| Germany | 4.9% |
| Japan | 5.2% |
| Australia | 5.8% |
The United States accounts for 27.6% of the global pharmaceutical filtration market. The country is among the leading pharmaceutical industry in the world, which means that the demand for pharmaceutical filtration is also very high in the United States. Private players in the fields of drug manufacturing and vaccine research have already poured billions of dollars into building the infrastructure required to meet the sky-touching demand for medical equipment.
The United States is also a market leader in the development of pharmaceutical filtration technologies. With the most advanced institutions like Parker Hannifin, Sartorius, and Thermo Fisher Scientific, the country is set to make huge breakthroughs, thus highlighting the significance of pharmaceutical filtration technology in the medical industry.
India is the third-leading pharma industry in the world, coupled with the fact that the medical infrastructure in the country is also very well developed. The recent pandemic and the demand for vaccines and medications required to fulfill the needs of the world’s largest population created huge opportunities for companies involved in the pharmaceutical filtration industry. The share of the international pharmaceutical filtration market in India is estimated at 12.5%.
The Central Drugs Standard Control Organization, the regulatory body in India, has curated strict standards for the safety and efficacy of pharmaceutical products. Apart from this, there have been huge investments in the pharma industry, which is a prime factor in the development of pharmaceutical filtration in India.
Category-wise, membrane filters dominate the pharmaceutical filtration market with a global share of 33.3%. Membrane filters have applications in numerous sectors, ranging from vaccines to small-molecule drugs. It is also used in the manufacturing of water and solvents used in the production of pharmaceutical drugs. This makes membrane filters the most versatile choice for companies associated with the pharma industry.
| Attributes | Details |
|---|---|
| By Category | Membrane filters |
| Market share | 33.3% |
Membrane filters are highly efficient and are widely preferred due to their ability to keep unwanted contaminants away from pharmaceutical solutions. It can also separate small viruses and bacteria from deteriorating the chemical formula of active pharmaceutical ingredients. Not only this, membrane filters can also filter out dissolved solid metals from solutions.
Membrane filters are relatively cost-effective as compared to other pharmaceutical filtration technologies. This makes the adoption of membrane filters very affordable for small-scale enterprises, which form the majority of pharmaceutical companies across the world. It is also very easy to use, and the maintenance cost in the long term is also comparatively low. These factors, coupled with the ease of availability of these filters in the international market, make them a favorable choice for all sizes of pharmaceutical companies.
The pharmaceutical filtration process is used in the manufacturing sector on a large scale. Operation-wise, the manufacturing sector contributes to 51.2% of the total revenue growth of the global pharmaceutical filtration market. Not just in the pharmaceutical industry, this innovative technology has been adopted by many industries, like the water and wastewater treatment industry, the food and beverage industry, the electronics industry, and many more. Membrane filters are very versatile and can be used in a wide range of products and services.
| Attributes | Details |
|---|---|
| By Scale of Operation | Manufacturing |
| Market share | 51.2% |
Filtrations using pharmaceutical membrane filters can be implemented in the food and beverage industry to decontaminate milk, wine, ready-to-serve drinks, alcohol, and beers. They are also used in wastewater treatments for the recycled use of industrial wastewater. It is also used to filter air in clean rooms where electronic components are assembled.
The pharmaceutical filtration industry is marked by intense competition, with several prominent players competing for dominance. Investors and industry players can capitalize on this by shifting toward active pharmaceutical ingredients to meet specific quality standards.
Industry experts in pharmaceutical filtration face substantial challenges, primarily from stringent environmental regulations and the growing scrutiny of finished products, the nature of products, and the manufacturing process.
Recent Developments in the Field of Pharmaceutical Filtration Market
The pharmaceutical filtration market is expected to register a growth of 8.9% CAGR.
The United States and India are the key producers of pharmaceutical filtration.
The United States, China, and India are expected to drive demand for the pharmaceutical filtration industry.
Membrane filters dominate the segment with a global share of 33.33%.
The market recorded a CAGR of 7.2% during the historical Period.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2023 to 2033
5.3.1. Manual Wheelchairs
5.3.2. Electrically Powered Wheelchairs
5.3.3. Stretchers
5.3.4. Walking Aids
5.3.5. Mobility Scooters
5.3.6. Stair Lifts
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
6.1. Introduction
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
6.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
6.3.1. North America
6.3.2. Latin America
6.3.3. Western Europe
6.3.4. Eastern Europe
6.3.5. South Asia and Pacific
6.3.6. East Asia
6.3.7. Middle East and Africa
6.4. Market Attractiveness Analysis By Region
7. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
7.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
7.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
7.2.1. By Country
7.2.1.1. The USA
7.2.1.2. Canada
7.2.2. By Product Type
7.3. Market Attractiveness Analysis
7.3.1. By Country
7.3.2. By Product Type
7.4. Key Takeaways
8. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. Brazil
8.2.1.2. Mexico
8.2.1.3. Rest of Latin America
8.2.2. By Product Type
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Product Type
8.4. Key Takeaways
9. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Germany
9.2.1.2. United Kingdom
9.2.1.3. France
9.2.1.4. Spain
9.2.1.5. Italy
9.2.1.6. Rest of Western Europe
9.2.2. By Product Type
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.4. Key Takeaways
10. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Poland
10.2.1.2. Russia
10.2.1.3. Czech Republic
10.2.1.4. Romania
10.2.1.5. Rest of Eastern Europe
10.2.2. By Product Type
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.4. Key Takeaways
11. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. India
11.2.1.2. Bangladesh
11.2.1.3. Australia
11.2.1.4. New Zealand
11.2.1.5. Rest of South Asia and Pacific
11.2.2. By Product Type
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.4. Key Takeaways
12. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Product Type
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.4. Key Takeaways
13. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. GCC Countries
13.2.1.2. South Africa
13.2.1.3. Israel
13.2.1.4. Rest of MEA
13.2.2. By Product Type
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.4. Key Takeaways
14. Key Countries Market Analysis
14.1. USA
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2022
14.1.2.1. By Product Type
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2022
14.2.2.1. By Product Type
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2022
14.3.2.1. By Product Type
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2022
14.4.2.1. By Product Type
14.5. Germany
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2022
14.5.2.1. By Product Type
14.6. United Kingdom
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2022
14.6.2.1. By Product Type
14.7. France
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2022
14.7.2.1. By Product Type
14.8. Spain
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2022
14.8.2.1. By Product Type
14.9. Italy
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2022
14.9.2.1. By Product Type
14.10. Poland
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2022
14.10.2.1. By Product Type
14.11. Russia
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2022
14.11.2.1. By Product Type
14.12. Czech Republic
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2022
14.12.2.1. By Product Type
14.13. Romania
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2022
14.13.2.1. By Product Type
14.14. India
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2022
14.14.2.1. By Product Type
14.15. Bangladesh
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2022
14.15.2.1. By Product Type
14.16. Australia
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2022
14.16.2.1. By Product Type
14.17. New Zealand
14.17.1. Pricing Analysis
14.17.2. Market Share Analysis, 2022
14.17.2.1. By Product Type
14.18. China
14.18.1. Pricing Analysis
14.18.2. Market Share Analysis, 2022
14.18.2.1. By Product Type
14.19. Japan
14.19.1. Pricing Analysis
14.19.2. Market Share Analysis, 2022
14.19.2.1. By Product Type
14.20. South Korea
14.20.1. Pricing Analysis
14.20.2. Market Share Analysis, 2022
14.20.2.1. By Product Type
14.21. GCC Countries
14.21.1. Pricing Analysis
14.21.2. Market Share Analysis, 2022
14.21.2.1. By Product Type
14.22. South Africa
14.22.1. Pricing Analysis
14.22.2. Market Share Analysis, 2022
14.22.2.1. By Product Type
14.23. Israel
14.23.1. Pricing Analysis
14.23.2. Market Share Analysis, 2022
14.23.2.1. By Product Type
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Product Type
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Sunrise Medical LLC
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.1.5.2. Product Strategy
16.1.1.5.3. Channel Strategy
16.1.2. Invacare Corporatio
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.2.5.2. Product Strategy
16.1.2.5.3. Channel Strategy
16.1.3. OttoBock Healthcare GmbH
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.3.5.2. Product Strategy
16.1.3.5.3. Channel Strategy
16.1.4. Stryker Corporation
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.4.5.2. Product Strategy
16.1.4.5.3. Channel Strategy
16.1.5. Medline Industries
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.5.5.2. Product Strategy
16.1.5.5.3. Channel Strategy
16.1.6. GF Health Products Inc
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.6.5.2. Product Strategy
16.1.6.5.3. Channel Strategy
16.1.7. Hoveround Corporation
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.7.5.2. Product Strategy
16.1.7.5.3. Channel Strategy
16.1.8. LEVO AG
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.8.5.2. Product Strategy
16.1.8.5.3. Channel Strategy
16.1.9. Permobil AB
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
16.1.9.5.2. Product Strategy
16.1.9.5.3. Channel Strategy
16.1.10. Merivaara Corporation
16.1.10.1. Overview
16.1.10.2. Product Portfolio
16.1.10.3. Profitability by Market Segments
16.1.10.4. Sales Footprint
16.1.10.5. Strategy Overview
16.1.10.5.1. Marketing Strategy
16.1.10.5.2. Product Strategy
16.1.10.5.3. Channel Strategy
17. Assumptions & Acronyms Used
18. Research Methodology
Explore Healthcare Insights
View Reports
Pharmaceutical Filtration Market
